| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084511345 |
| P356 | DOI | 10.1038/CR.2017.51 |
| P8608 | Fatcat ID | release_3b2kksxlunazjpkjwselzu2crm |
| P932 | PMC publication ID | 5518983 |
| P698 | PubMed publication ID | 28374746 |
| P50 | author | Michael T Lotze | Q89121415 |
| Herbert J. Zeh, III | Q92244196 | ||
| David L Bartlett | Q97424233 | ||
| Timothy Billiar | Q30223707 | ||
| Haichao Wang | Q37375045 | ||
| P2093 | author name string | Daolin Tang | |
| Rui Kang | |||
| Shan Zhu | |||
| Jinbao Liu | |||
| Wen Hou | |||
| Yangchun Xie | |||
| Qiuhong Zhang | |||
| Dexing Zeng | |||
| Qingping Jiang | |||
| P2860 | cites work | Endogenous HMGB1 regulates autophagy | Q24298865 |
| Chromosomal instability and cancer: a complex relationship with therapeutic potential | Q24608609 | ||
| Pancreatic ductal cells in development, regeneration, and neoplasia | Q27006729 | ||
| Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage | Q27312357 | ||
| Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury | Q27334890 | ||
| RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA | Q27680115 | ||
| HMGB1-facilitated p53 DNA binding occurs via HMG-Box/p53 transactivation domain interaction, regulated by the acidic tail | Q27682786 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 | ||
| HMGB1 and RAGE in inflammation and cancer | Q28274621 | ||
| Masquerader: high mobility group box-1 and cancer | Q28302492 | ||
| Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance | Q28504893 | ||
| SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
| Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. | Q53371627 | ||
| Pancreatic Adenocarcinoma | Q55880513 | ||
| Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases | Q59084980 | ||
| Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer | Q60594558 | ||
| The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins | Q67601392 | ||
| Long-term stability of circulating nucleosomes in serum | Q84510027 | ||
| SOX9 is required for maintenance of the pancreatic progenitor cell pool | Q28510325 | ||
| High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage | Q28513347 | ||
| THE COMPLEX STRUCTURE AND DYNAMIC EVOLUTION OF HUMAN SUBTELOMERES | Q29393384 | ||
| DAMPs, PAMPs and alarmins: all we need to know about danger | Q29547535 | ||
| GammaH2AX and cancer | Q29614974 | ||
| Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice | Q29617045 | ||
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Q29620396 | ||
| Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE | Q29620722 | ||
| A combination of molecular markers and clinical features improve the classification of pancreatic cysts | Q30724746 | ||
| Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice | Q33604913 | ||
| Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression | Q33787458 | ||
| KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. | Q33858490 | ||
| Pancreatic cancer, inflammation, and microbiome | Q33956107 | ||
| Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy | Q34118056 | ||
| Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions | Q34244725 | ||
| New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal | Q34334123 | ||
| The epidemiology of pancreatitis and pancreatic cancer | Q34341477 | ||
| Organoid models of human and mouse ductal pancreatic cancer | Q34456438 | ||
| RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer | Q34541682 | ||
| HMGB1 in health and disease | Q34622835 | ||
| Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. | Q34786695 | ||
| Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas | Q34792019 | ||
| Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice | Q34874768 | ||
| 8-Hydroxyguanine: From its discovery in 1983 to the present status | Q35068187 | ||
| Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output | Q35073809 | ||
| Drugging the undruggable RAS: Mission possible? | Q35163434 | ||
| Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death | Q35164703 | ||
| Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury | Q35175597 | ||
| Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. | Q35183879 | ||
| Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice | Q35541859 | ||
| Release and activity of histone in diseases | Q35679542 | ||
| High-mobility group box 1 is essential for mitochondrial quality control | Q35800479 | ||
| The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia | Q35935777 | ||
| HMGB1 is a therapeutic target for sterile inflammation and infection | Q35953553 | ||
| Sox9 coordinates a transcriptional network in pancreatic progenitor cells | Q35973342 | ||
| MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. | Q36193536 | ||
| TLR9 ligation in pancreatic stellate cells promotes tumorigenesis | Q36286020 | ||
| The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma | Q36384268 | ||
| RAGE signaling sustains inflammation and promotes tumor development | Q36502858 | ||
| Epithelial metaplasia and the development of cancer. | Q36873310 | ||
| The Receptor for Advanced Glycation End Products Activates the AIM2 Inflammasome in Acute Pancreatitis. | Q36905963 | ||
| HMGB1 in cancer: good, bad, or both? | Q37067481 | ||
| The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics | Q37227378 | ||
| Molecular classification of neoplasms of the pancreas | Q37442092 | ||
| Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia | Q37501557 | ||
| Molecular and cellular regulation of pancreatic acinar cell function | Q37538446 | ||
| SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms | Q37621990 | ||
| Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice | Q37662678 | ||
| Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? | Q37897800 | ||
| Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology. | Q37923241 | ||
| What we have learned about pancreatic cancer from mouse models. | Q37992454 | ||
| Predictive in vivo animal models and translation to clinical trials | Q38001718 | ||
| Exocrine ontogenies: on the development of pancreatic acinar, ductal and centroacinar cells | Q38022404 | ||
| Relevance of animal models of pancreatic cancer and pancreatitis to human disease | Q38102104 | ||
| Dragging ras back in the ring | Q38197825 | ||
| Pancreatic cancer: from state-of-the-art treatments to promising novel therapies | Q38396634 | ||
| KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis | Q38786245 | ||
| NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas. | Q38916311 | ||
| HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction. | Q39356760 | ||
| STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. | Q39540918 | ||
| High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy | Q40099916 | ||
| Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice | Q40679145 | ||
| Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response | Q40899986 | ||
| Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells | Q41697061 | ||
| Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | Q41856856 | ||
| Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities | Q42828870 | ||
| Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia | Q42937848 | ||
| Nucleosomes in serum as a marker for cell death | Q43719377 | ||
| Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma | Q46279328 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 916-932 | |
| P577 | publication date | 2017-04-04 | |
| P1433 | published in | Cell Research | Q1524018 |
| P1476 | title | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer | |
| P478 | volume | 27 |
| Q48341352 | Anticancer and Immunogenic Properties of Cardiac Glycosides |
| Q64112676 | Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
| Q64237150 | Cancer-cell-secreted CXCL11 promoted CD8 T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC |
| Q92540151 | Effects of neoadjuvant FOLFIRONOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma |
| Q104459068 | Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway |
| Q47391467 | HMGB1 Controls Liver Cancer Initiation through YAP-dependent Aerobic Glycolysis. |
| Q57109153 | HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium |
| Q55343196 | HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect. |
| Q92015253 | Identification of a key candidate gene‑phenotype network mediated by glycyrrhizic acid using pharmacogenomic analysis |
| Q38695950 | Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma |
| Q90029047 | Insights into telomeric G-quadruplex DNA recognition by HMGB1 protein |
| Q47285488 | JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice |
| Q92404751 | Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1 |
| Q89907564 | Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells |
| Q87853391 | MicroRNA-935 inhibits proliferation and invasion of osteosarcoma cells by directly targeting High mobility group box 1 |
| Q57461792 | Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells |
| Q92507403 | Prolactin Promotes Fibrosis and Pancreatic Cancer Progression |
| Q52584324 | Proteomic biomarkers in body fluids associated with pancreatic cancer. |
| Q89484239 | RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review |
| Q55191109 | RAGE-specific single chain Fv for PET imaging of pancreatic cancer. |
| Q52609417 | Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis. |
| Q52720171 | Regulation of Tumor Progression by Programmed Necrosis. |
| Q101121160 | Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis |
| Q61631793 | The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis |
| Q64261339 | The dark side of radiotherapy-induced cell death in cancer |
| Q92669310 | Tumor suppressor function of miR-129-5p in lung cancer |
| Q99564729 | Tumor-derived HMGB1 induces CD62Ldim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer |
Search more.